<DOC>
	<DOCNO>NCT00004392</DOCNO>
	<brief_summary>OBJECTIVES : I. Assess compare incidence severity cardiorespiratory event document home monitoring infant increase epidemiological risk sudden infant death syndrome ( SIDS ) . II . Determine antecedent medical , demographic , physiologic , behavioral characteristic predict incidence cardiorespiratory event document home monitoring .</brief_summary>
	<brief_title>Incidence Severity Cardiorespiratory Events Infants Increased Epidemiological Risk Sudden Infant Death Syndrome ( SIDS )</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This multicenter collaborative study . Patients stratify 4 group : healthy term infant , apnea infancy , subsequent sibling SIDS victim , preterm infant . The caregiver train use home monitor equipment grade response monitor alarm ( observation , gentle stimulation , vigorous stimulation , mouth mouth breathing , full cardiopulmonary resuscitation ) . Caregivers undergo infant cardiopulmonary resuscitation ( CPR ) training ( required caregiver healthy term infant ) . Demographic information obtain infant . A 30 second record infant 's cry perform study entry 1 month correct age , polysomnogram . A urine sample collect frozen . The CHIME monitor use sleep whenever infant observe . An overnight polysomnography perform within 2 week study entry . At 1 , 2.5 , 6 , 12 month correct age , infant participate clinical evaluation . Neurodevelopmental status assess 1 , 4 , 12 month correct age .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Death</mesh_term>
	<mesh_term>Infant Death</mesh_term>
	<mesh_term>Sudden Infant Death</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Healthy term infant infant high epidemiologic risk SIDS meet one follow criterion : Apnea infancy Siblings SIDS victim Preterm infants Prior/Concurrent Therapy All study group : No home treatment supplemental oxygen , bronchodilator , diuretic , steroid , respiratory stimulant methylxanthines Healthy term infant : No prior/concurrent medication treatment except : Vitamins Eye prophylaxis Vaccines Patient Characteristics All study group : No concurrent pneumonia No history congenital heart disease Current asymptomatic PDA ASD , small muscular VSD , require treatment allow No ventriculoperitoneal shunt No home anticonvulsant therapy No congenital brain anomaly document head ultrasound , CT , MRI No gastroesophageal reflux treat medication No midfacial hypoplasia cleft palate No prior inborn error metabolism ( include MCAD carnitine deficiency ) No caregiver currently use illicit drug No language barrier researcher caregiver Must telephone home Healthy term infant : Gestational age birth 3842 week Age great 30 day postnatally plan monitor start date Not admit special care nursery Nursery discharge on/before date maternal discharge 48 hour age , whichever later No history apnea apparent life threaten event ( ALTE ) No history SIDS full half siblings No history SIDS cousin , aunt , uncle last 10 year 1 minute APGAR least 4 5 minute APGAR least 7 Apnea infancy : Diagnosed ALTE ( sleep awake ) characterize color change , muscle tone change , apnea require intervention No specific etiology ALTE thorough diagnostic evaluation At least 12 hour age less 6 month postnatal age ALTE occur Greater 34 week gestation Weight great 1750 g Siblings SIDS victim Half full sibling least one previous SIDS victim Less 1 month postnatal age study entry Autopsy report confirm SIDS sibling Preterm infant Birth weight less 1750 g Gestational age great 34 week Postnatal age le 120 day time hospital discharge</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>January 2000</verification_date>
	<keyword>apnea</keyword>
	<keyword>cardiovascular respiratory disease</keyword>
	<keyword>neurologic psychiatric disorder</keyword>
	<keyword>rare disease</keyword>
	<keyword>sudden infant death syndrome</keyword>
</DOC>